Citations (85)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Chuanhui Song, Chuanchao Tang, Wenguang Xu, Jianchuan Ran, Zheng Wei, Yufeng Wang, Huihui Zou, Wei Cheng, Yu Cai & Wei Han. (2020) Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma. International Journal of Nanomedicine 15, pages 347-361.
Read now
Read now
Pouya Saraei, Ilia Asadi, Muhammad Azam Kakar & Nasroallah Moradi-Kor. (2019) The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances. Cancer Management and Research 11, pages 3295-3313.
Read now
Read now
Mingyue Rao, Chenlin Gao, Man Guo, Betty Yuen Kwan Law & Yong Xu. (2018) Effects of metformin treatment on radiotherapy efficacy in patients with cancer and diabetes: a systematic review and meta-analysis. Cancer Management and Research 10, pages 4881-4890.
Read now
Read now
Articles from other publishers (82)
Jan O. Kemnade, Marcus Florez, Anita Sabichi, Jun Zhang, Pavan Jhaveri, George Chen, Albert Chen, Courtney Miller-Chism, Bulsara Shaun, Susan G. Hilsenbeck, David J. Hernandez, Heath D. Skinner & Vlad C. Sandulache. (2023) Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Oral Oncology 145, pages 106536.
Crossref
Crossref
Vincenzo De Falco, Pasquale Vitale, Christian Brancati, Giuseppe Cicero, Annunziata Auriemma & Raffaele Addeo. (2023) Prognostic value of diabetes and metformin use in a real-life population of head and neck cancer patients. Frontiers in Medicine 10.
Crossref
Crossref
Croí E. Buckley, Rebecca M. O’Brien, Timothy S. Nugent, Noel E. Donlon, Fiona O’Connell, John V. Reynolds, Adnan Hafeez, Diarmuid S. O’Ríordáin, Robert A. Hannon, Paul Neary, Reza Kalbassi, Brian J. Mehigan, Paul H. McCormick, Cara Dunne, Michael E. Kelly, John O. Larkin, Jacintha O’Sullivan & Niamh Lynam-Lennon. (2023) Metformin is a metabolic modulator and radiosensitiser in rectal cancer. Frontiers in Oncology 13.
Crossref
Crossref
Qiao-Li Wang, Giola Santoni & Jesper Lagergren. (2023) Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study. JNCI Cancer Spectrum 7:4.
Crossref
Crossref
Kate Brown, Lisa M. Miller Jenkins, Daniel R. Crooks, Deborah R. Surman, Sharlyn J. Mazur, Yuan Xu, Bhargav S. Arimilli, Ye Yang, Andrew N. Lane, Teresa W-M. Fan, David S. Schrump, W. Marston Linehan, R. Taylor Ripley & Ettore Appella. (2023) Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile. Frontiers in Oncology 12.
Crossref
Crossref
Christine E. Alvarado, Kevin C. Kapcio, Michal J. Lada, Philip A. Linden, Christopher W. Towe & Stephanie G. Worrell. (2023) The Effect of Diabetes on Pathologic Complete Response Among Patients With Esophageal Cancer. Seminars in Thoracic and Cardiovascular Surgery 35:2, pages 429-436.
Crossref
Crossref
Annika Dhawan, Phillip M. Pifer, Vlad C. Sandulache & Heath D. Skinner. (2022) Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?. Frontiers in Oncology 12.
Crossref
Crossref
Kyoko Sakamoto, Koji Okabayashi, Shimpei Matsui, Ryo Seishima, Kohei Shigeta & Yuko Kitagawa. (2022) Association of Tumor Pathological Response with the Use of Metformin During Neoadjuvant Chemoradiotherapy in Rectal and Esophageal/Gastroesophageal Cancer Patients: a Systematic Review and Meta-analysis. Journal of Gastrointestinal Surgery 26:10, pages 2227-2236.
Crossref
Crossref
Mattia Zaffaroni, Maria Giulia Vincini, Giulia Corrao, Giulia Marvaso, Matteo Pepa, Giuseppe Viglietto, Nicola Amodio & Barbara Alicja Jereczek-Fossa. (2022) Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy. International Journal of Molecular Sciences 23:19, pages 11343.
Crossref
Crossref
Stephanie G. Worrell, Christine E. Alvarado, Dylan Thibault, Christopher W. Towe, John D. Mitchell, Andrew Vekstein, Andrzej S. Kosinski, Matthew G. Hartwig & Philip A. Linden. (2022) Impact of Diabetes on Pathologic Response to Multimodality Therapy for Esophageal Cancer. The Annals of Thoracic Surgery.
Crossref
Crossref
Raymond Chang. 2022. Drug Repurposing - Molecular Aspects and Therapeutic Applications. Drug Repurposing - Molecular Aspects and Therapeutic Applications.
Kwan-Ling Yip, Tsen-Ni Tsai, I-Ping Yang, Zhi-Feng Miao, Yen-Cheng Chen, Ching-Chun Li, Wei-Chih Su, Tsung-Kun Chang, Ching-Wen Huang, Hsiang-Lin Tsai, Yung-Sung Yeh & Jaw-Yuan Wang. (2022) Metformin Enhancement of Therapeutic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells and Nude Mice. Biomedicines 10:5, pages 955.
Crossref
Crossref
Joel L. Mayerson. (2022) CORR Insights®: Is Metformin Use Associated with Prolonged Overall Survival In Patients with Soft Tissue Sarcoma? A SEER-Medicare Study. Clinical Orthopaedics & Related Research 480:4, pages 745-747.
Crossref
Crossref
Ratna Veeramachaneni, Wangjie Yu, Jared M Newton, Jan O Kemnade, Heath D Skinner, Andrew G Sikora & Vlad C Sandulache. (2021) Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects. Journal for ImmunoTherapy of Cancer 9:7, pages e002773.
Crossref
Crossref
Anaís Sánchez-Castillo, Marc Vooijs & Kim R. Kampen. (2021) Linking Serine/Glycine Metabolism to Radiotherapy Resistance. Cancers 13:6, pages 1191.
Crossref
Crossref
Alaba Tolulope Agbele, Oluwayomi Peace Faromika, Olufisayo Olalekan Awe, Funke Roseline Amodu, Goodness Oreoluwa Edaogbogun & Kalid Abayomi Bello. (2021) Impact of metformin on the therapeutic effect of radiotherapy. Radiation Medicine and Protection 2:1, pages 17-22.
Crossref
Crossref
Tomas Koltai, Stephan J. Reshkin, Fátima Baltazar & Larry Fliegel. 2021. Prostate Cancer Metabolism. Prostate Cancer Metabolism
37
62
.
Dong Chen, Fu-Ju Chou, Yuhchyau Chen, Hao Tian, Yaqin Wang, Bosen You, Yuanjie Niu, Chi-Ping Huang, Shuyuan Yeh, Nianzeng Xing & Chawnshang Chang. (2020) Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity. Cancer Letters 495, pages 100-111.
Crossref
Crossref
Martin Kery & Ioanna Papandreou. (2020) Emerging strategies to target cancer metabolism and improve radiation therapy outcomes. The British Journal of Radiology 93:1115, pages 20200067.
Crossref
Crossref
Benjamin Chevalier, David Pasquier, Eric Felix Lartigau, Cyrus Chargari, Antoine Schernberg, Arnaud Jannin, Xavier Mirabel, Marie-Christine Vantyghem & Alexandre Escande. (2020) Metformin: (future) best friend of the radiation oncologist?. Radiotherapy and Oncology 151, pages 95-105.
Crossref
Crossref
Wangjie Yu, Yunyun Chen, Nagireddy Putluri, Cristian Coarfa, Matthew J. Robertson, Vasanta Putluri, Fabio Stossi, Julien Dubrulle, Michael A. Mancini, Jonathan C. Pang, Trung Nguyen, Dodge Baluya, Jeffrey N. Myers, Stephen Y. Lai & Vlad C. Sandulache. (2020) Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell Carcinoma Metabolism toward Neutralization of Oxidative Stress. Cancers 12:6, pages 1670.
Crossref
Crossref
Rodrigo Oliva Perez, Laura M. Fernandez & Cinthia D. Ortega. (2020) Metformin Use in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation: The New Magic Bullet?. Diseases of the Colon & Rectum 63:6, pages 718-719.
Crossref
Crossref
Mitchell Frederick, Heath D. Skinner, Sawad A. Kazi, Andrew G. Sikora & Vlad C. Sandulache. (2020) High expression of oxidative phosphorylation genes predicts improved survival in squamous cell carcinomas of the head and neck and lung. Scientific Reports 10:1.
Crossref
Crossref
Xufei Bian, Lan Jiang, Jing Zhou, Xiaoshu Guan, Jingyu Wang, Peng Xiang, Junyi Pan & Xiangnan Hu. (2020) Improving Dissolution and Cytotoxicity by Forming Multidrug Crystals. Molecules 25:6, pages 1343.
Crossref
Crossref
Xi Zheng, Xingsheng Ma, Han-Yu Deng, Panpan Zha, Jie Zhou, Ru-Lan Wang & Rui Jiang. (2020) Diabetes mellitus and survival of esophageal cancer patients after esophagectomy: a systematic review and meta-analysis. Diseases of the Esophagus 33:2.
Crossref
Crossref
Taryn E. Hassinger, Adam C. Berger, Adrienne Christopher, Anne T. Knisely, J. Hunter Mehaffey, David R. Brenin, Anneke T. Schroen & Shayna L. Showalter. (2020) Diabetes Mellitus and Metformin Are Not Associated With Breast Cancer Pathologic Complete Response. Journal of Surgical Research 247, pages 52-58.
Crossref
Crossref
Yile Jiao, Xiaochen Wang & Zhijun Luo. 2020. Metformin [Working Title]. Metformin [Working Title].
Elizabeth G. Ratcliffe, Mohamed Shibeika, Andrew D. Higham & Janusz A. Jankowski. 2020. Esophageal Cancer. Esophageal Cancer
113
125
.
Daniel J. Lee, Caitlin P. McMullen, Andrew Foreman, Shao Hui Huang, Lin Lu, Wei Xu, John R. de Almeida, Geoffrey Liu, Scott V. Bratman & David P. Goldstein. (2019) Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study. Journal of Otolaryngology - Head & Neck Surgery 48:1.
Crossref
Crossref
Yuyang Liu, Xiangnan Hu, Xuefeng Shan, Ke Chen & Hua Tang. (2019) Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway. Cancer Cell International 19:1.
Crossref
Crossref
Yung-An Tsou, Wen-Dien Chang, Jian-Ji Lu, Tsu-Fang Wu, Hsiao-Ling Chen, Chuan-Mu Chen & Ming Hsui Tsai. (2019) The effect of metformin use on hypopharyngeal squamous cell carcinoma in diabetes mellitus patients. BMC Cancer 19:1.
Crossref
Crossref
Stephen L. Brown, Andrew Kolozsvary, Derek M. Isrow, Karine Al Feghali, Karen Lapanowski, Kenneth A. Jenrow & Jae Ho Kim. (2019) A Novel Mechanism of High Dose Radiation Sensitization by Metformin. Frontiers in Oncology 9.
Crossref
Crossref
Susan Short, Edward Fielder, Satomi Miwa & Thomas von Zglinicki. (2019) Senolytics and senostatics as adjuvant tumour therapy. EBioMedicine 41, pages 683-692.
Crossref
Crossref
John C. Dawson, Scott J. Warchal & Neil O. Carragher. 2019. Reverse Phase Protein Arrays. Reverse Phase Protein Arrays
203
226
.
McFarlane Samy I. (2018) Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy. Global Journal of Obesity, Diabetes and Metabolic Syndrome, pages 008-014.
Crossref
Crossref
Olivia Lacroix, Alexandra Couttenier, Evelien Vaes, Chris R. Cardwell, Harlinde De Schutter & Annie Robert. (2018) Impact of metformin on gastric adenocarcinoma survival: A Belgian population based study. Cancer Epidemiology 53, pages 149-155.
Crossref
Crossref
Lobna Al-Zaidan, Rasha Abu El Ruz & Ahmed M. Malki. (2017) Screening Novel Molecular Targets of Metformin in Breast Cancer by Proteomic Approach. Frontiers in Public Health 5.
Crossref
Crossref
Linda Sleire, Hilde Elise Førde, Inger Anne Netland, Lina Leiss, Bente Sandvei Skeie & Per Øyvind Enger. (2017) Drug repurposing in cancer. Pharmacological Research 124, pages 74-91.
Crossref
Crossref
Joseph CurryJennifer JohnsonPatrick Tassone, Marina Domingo VidalDiana Whitaker MenezesJohn SprandioMehri MollaeePaolo CotziaRuth BirbeZhao LinKurren Gill, Elizabeth DuddyTingting ZhanBenjamin LeibyMichelle ReyzerDavid CognettiAdam LuginbuhlMadalina TulucUbaldo Martinez‐Outschoorn. (2017) Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial. The Laryngoscope 127:8, pages 1808-1815.
Crossref
Crossref
Jian-Cai Tang, Rui An, Yi-Qing Jiang & Jian Yang. (2017) Effects and Mechanisms of Metformin on the Proliferation of Esophageal Cancer Cells In Vitro and In Vivo. Cancer Research and Treatment 49:3, pages 778-789.
Crossref
Crossref
Nur Atiqah Binte Samsuri, Michelle Leech & Laure Marignol. (2017) Metformin and improved treatment outcomes in radiation therapy ? A review. Cancer Treatment Reviews 55, pages 150-162.
Crossref
Crossref
Michael Pawlak & Neil O. Carragher. (2017) Reverse Phase Protein Arrays elucidate mechanisms-of-action and phenotypic response in 2D and 3D models. Drug Discovery Today: Technologies 23, pages 7-16.
Crossref
Crossref
L. Raffaghello & V. Longo. 2017.
1
42
.
Xiaofeng Qi, Wengguang Xu, Junqi Xie, Yufeng Wang, Shengwei Han, Zheng Wei, Yanhong Ni, Yingchun Dong & Wei Han. (2016) Metformin sensitizes the response of oral squamous cell carcinoma to cisplatin treatment through inhibition of NF-κB/HIF-1α signal axis. Scientific Reports 6:1.
Crossref
Crossref
Sanjana Chowdhury, Eric Yung, Melania Pintilie, Hala Muaddi, Selim Chaib, ManTek Yeung, Manlio Fusciello, Jenna Sykes, Bethany Pitcher, Anna Hagenkort, Trevor McKee, Ravi Vellanki, Eric Chen, Robert G. Bristow, Bradly G. Wouters & Marianne Koritzinsky. (2016) MATE2 Expression Is Associated with Cancer Cell Response to Metformin. PLOS ONE 11:12, pages e0165214.
Crossref
Crossref
Eun Ho Kim, Mi-Sook Kim, Yoshiya Furusawa, Akiko Uzawa, Soorim Han, Won-Gyun Jung & Sei Sai. (2016) Metformin enhances the radiosensitivity of human liver cancer cells to γ–rays and carbon ion beams. Oncotarget 7:49.
Crossref
Crossref
Zachery R. Reichert, Daniel R. Wahl & Meredith A. Morgan. (2016) Translation of Targeted Radiation Sensitizers into Clinical Trials. Seminars in Radiation Oncology 26:4, pages 261-270.
Crossref
Crossref
Vera Hirsh, Amy Ko, Richard Pilot, Markus F. Renschler & Mark A. Socinski. (2016) Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non?Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Diabetes. Clinical Lung Cancer 17:5, pages 367-374.
Crossref
Crossref
Hongxin Cao, Wei Dong, Xiao Qu, Hongchang Shen, Jun Xu, Linhai Zhu, Qi Liu & Jiajun Du. (2016) Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC. Scientific Reports 6:1.
Crossref
Crossref
Scott J Warchal, Asier Unciti-Broceta & Neil O Carragher. (2016) Next-generation phenotypic screening. Future Medicinal Chemistry 8:11, pages 1331-1347.
Crossref
Crossref
Bo Young Oh, Yoon Ah Park, Jung Wook Huh, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Hee Chul Park, Doo Ho Choi, Young Suk Park & Hee Cheol Kim. (2016) Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer. Journal of Cancer Research and Clinical Oncology 142:6, pages 1377-1385.
Crossref
Crossref
Zhigui Guo, Manqing Cao, Abin You, Junrong Gao, Hongyuan Zhou, Huikai Li, Yunlong Cui, Feng Fang, Wei Zhang, Tianqiang Song, Qiang Li, Xiaolin Zhu, Huichuan Sun & Ti Zhang. (2016) Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30. Cancer Science 107:4, pages 507-513.
Crossref
Crossref
Krista C.J. Wink, José S.A. Belderbos, Edith M.T. Dieleman, Maddalena Rossi, Coen R.N. Rasch, Ronald A.M. Damhuis, Ruud M.A. Houben & Esther G.C. Troost. (2016) Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy. Radiotherapy and Oncology 118:3, pages 453-459.
Crossref
Crossref
Tadashi Matsuoka, Hiroharu Shinozaki, Hiroki Ozawa, Ryo Nakanishi, Tetsuichiro Shimizu, Takashi Ishida, Toshiaki Terauchi, Masaru Kimata, Kenji Kobayashi & Yoshiro Ogata. (2016) Juvenile Rectal Cancer in a Family with Li-Fraumeni Syndrome. The Japanese Journal of Gastroenterological Surgery 49:11, pages 1170-1178.
Crossref
Crossref
L. E. A. M. M. Spierings, S. M. Lagarde, M. G. H. van Oijen, S. S. Gisbertz, J. W. Wilmink, M. C. C. M. Hulshof, S. L. Meijer, M. C. Anderegg, M. I. van Berge Henegouwen & H. W. M. van Laarhoven. (2015) Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes. Annals of Surgical Oncology 22:S3, pages 766-771.
Crossref
Crossref
Li-Ru He, Wei Qiao, Zhong-Xing Liao, Ritsuko Komaki, Linus Ho, Wayne L Hofstetter & Steven H Lin. (2015) Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma. BMC Cancer 15:1.
Crossref
Crossref
Aaron P. Thrift. (2015) Esophageal Adenocarcinoma: The Influence of Medications Used to Treat Comorbidities on Cancer Prognosis. Clinical Gastroenterology and Hepatology 13:13, pages 2225-2232.
Crossref
Crossref
Sebastian Adeberg, Denise Bernhardt, Semi Ben Harrabi, Tilman Bostel, Angela Mohr, Christian Koelsche, Christian Diehl, Stefan Rieken & Juergen Debus. (2015) Metformin influences progression in diabetic glioblastoma patientsMetforminbeeinflusst die Progression bei diabetischen Glioblastompatienten. Strahlentherapie und Onkologie 191:12, pages 928-935.
Crossref
Crossref
Walter Lemmo. (2014) Potential interactions of prescription and over‐the‐counter medications having antioxidant capabilities with radiation and chemotherapy. International Journal of Cancer 137:11, pages 2525-2533.
Crossref
Crossref
Abbas Shafaee, Davood Zarei Dastyar, Jalil Pirayesh Islamian & Milad Hatamian. (2015) Inhibition of tumor energy pathways for targeted esophagus cancer therapy. Metabolism 64:10, pages 1193-1198.
Crossref
Crossref
Marianne Koritzinsky. (2015) Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics 93:2, pages 454-464.
Crossref
Crossref
L. Van De Voorde, L. Janssen, R. Larue, R. Houben, J. Buijsen, M. Sosef, B. Vanneste, M.-C. Schraepen, M. Berbée & P. Lambin. (2015) Can metformin improve ‘the tomorrow’ of patients treated for oesophageal cancer?. European Journal of Surgical Oncology (EJSO) 41:10, pages 1333-1339.
Crossref
Crossref
Dörthe Schaue & William H. McBride. (2015) Opportunities and challenges of radiotherapy for treating cancer. Nature Reviews Clinical Oncology 12:9, pages 527-540.
Crossref
Crossref
Quinn Matthews, Martin Isabelle, Samantha J. Harder, Julian Smazynski, Wayne Beckham, Alexandre G. Brolo, Andrew Jirasek & Julian J. Lum. (2015) Radiation-Induced Glycogen Accumulation Detected by Single Cell Raman Spectroscopy Is Associated with Radioresistance that Can Be Reversed by Metformin. PLOS ONE 10:8, pages e0135356.
Crossref
Crossref
Alexander Lin & Amit Maity. (2015) Molecular Pathways: A Novel Approach to Targeting Hypoxia and Improving Radiotherapy Efficacy via Reduction in Oxygen Demand. Clinical Cancer Research 21:9, pages 1995-2000.
Crossref
Crossref
Geoff S. Higgins, Sean M. O’Cathail, Ruth J. Muschel & W. Gillies McKenna. (2015) Drug radiotherapy combinations: Review of previous failures and reasons for future optimism. Cancer Treatment Reviews 41:2, pages 105-113.
Crossref
Crossref
Daniel R. Morales & Andrew D. Morris. (2015) Metformin in Cancer Treatment and Prevention. Annual Review of Medicine 66:1, pages 17-29.
Crossref
Crossref
Haiwen Li, Xinggui Chen, Ying Yu, Zhennan Wang, Yufang Zuo, Shuhui Li, Donghong Yang, Shengwen Hu, Mei Xiang, Zumin Xu & Zhonghua Yu. (2014) Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway. Oncology Reports.
Crossref
Crossref
Amato J. Giaccia. (2014) Molecular Radiobiology: The State of the Art. Journal of Clinical Oncology 32:26, pages 2871-2878.
Crossref
Crossref
Aisha Fasih, Hosam A. Elbaz, Maik Hüttemann, Andre A. Konski & Steven P. Zielske. (2014) Radiosensitization of Pancreatic Cancer Cells by Metformin through the AMPK Pathway. Radiation Research 182:1, pages 50-59.
Crossref
Crossref
Vlad C. Sandulache, John S. Hamblin, Heath D. Skinner, Mark W. Kubik, Jeffrey N. Myers & Jose P. Zevallos. (2014) Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma. Head & Neck 36:7, pages 1039-1043.
Crossref
Crossref
Soichiro Honjo, Jaffer Ajani, Ailing Scott, Qiongrong Chen, Heath Skinner, John Stroehlein, Randy Johnson & Shumei Song. (2014) Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer. International Journal of Oncology.
Crossref
Crossref
Y Feng, C Ke, Q Tang, H Dong, X Zheng, W Lin, J Ke, J Huang, S-CJ Yeung & H Zhang. (2014) Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling. Cell Death & Disease 5:2, pages e1088-e1088.
Crossref
Crossref
Vlad C. Sandulache, Liangpeng Yang & Heath D. Skinner. 2014. Cancer Cell Signaling. Cancer Cell Signaling
3
9
.
Vanessa E. Zannella, Alan Dal Pra, Hala Muaddi, Trevor D. McKee, Shawn Stapleton, Jenna Sykes, Rachel Glicksman, Selim Chaib, Paul Zamiara, Michael Milosevic, Bradly G. Wouters, Robert G. Bristow & Marianne Koritzinsky. (2013) Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response. Clinical Cancer Research 19:24, pages 6741-6750.
Crossref
Crossref
Tiange Wang, Guang Ning & Zachary Bloomgarden. (2013) Diabetes and cancer relationships (糖尿病与肿瘤的关联性). Journal of Diabetes 5:4, pages 378-390.
Crossref
Crossref
Mariela A. Blum, Takashi Taketa, Kazuki Sudo, Roopma Wadhwa, Heath D. Skinner & Jaffer A. Ajani. (2013) Chemoradiation for Esophageal Cancer. Thoracic Surgery Clinics 23:4, pages 551-558.
Crossref
Crossref
Claudia Becker, Christoph R. Meier, Susan S. Jick & Michael Bodmer. (2013) Case?control analysis on metformin and cancer of the esophagus. Cancer Causes & Control 24:10, pages 1763-1770.
Crossref
Crossref
Michael Baumann, Stephan Bodis, Ekkehard Dikomey, Albert van der Kogel, Jens Overgaard, Hans Peter Rodemann & Bradly Wouters. (2013) Molecular radiation biology/oncology at its best: Cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology. Radiotherapy and Oncology 108:3, pages 357-361.
Crossref
Crossref
Hala Muaddi, Sanjana Chowdhury, Ravi Vellanki, Paul Zamiara & Marianne Koritzinsky. (2013) Contributions of AMPK and p53 dependent signaling to radiation response in the presence of metformin. Radiotherapy and Oncology 108:3, pages 446-450.
Crossref
Crossref
Christos V. Rizos & Moses S. Elisaf. (2013) Metformin and cancer. European Journal of Pharmacology 705:1-3, pages 96-108.
Crossref
Crossref
April D. Sorrell, Carin R. Espenschied, Julie O. Culver & Jeffrey N. Weitzel. (2013) Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome. Molecular Diagnosis & Therapy 17:1, pages 31-47.
Crossref
Crossref